Anti-angiogenic peptide

Abstract

The present invention relates to a novel peptide that exhibits vascular inhibitory activity; specifically, the novel peptide, according to the present invention, binds to endothelial growth factor receptors. VEGFS in competition with vascular VEGF It can significantly inhibit the proliferation, migration, and differentiation of vascular endothelial cells. Therefore, the peptide, according to the present invention, has the advantage of being effectively usable as an active ingredient in a health-promoting functional food for the prevention or treatment of diseases, such as macular degeneration, rheumatoid arthritis, or psoriasis caused by excessive blood vessel formation.